Truncation and fusion of HMGA2 in lipomas with rearrangements of 5q32→q33 and 12q14→q15

Cytogenetic and Genome Research

Volumn 112, Issue 1-2, 2006, Pages 60-66

  Nilsson, M ^a   Mertens, F ^a   Hoglund M ^a   Mandahl, N ^a   Panagopoulos, I ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP A2 PROTEIN;

ADULT; AGED; ARTICLE; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE ACTIVATION; GENE CLUSTER; GENE FUSION; GENE IDENTIFICATION; GENE STRUCTURE; GENE TRANSLOCATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; LIPOMA; MALE; MOLECULAR DYNAMICS; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL;

ADULT; AGED; BASE SEQUENCE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 5; DNA PRIMERS; FEMALE; GENE FUSION; GENE REARRANGEMENT; GENETIC MARKERS; HMGA2 PROTEIN; HUMANS; KARYOTYPING; LIPOMA; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE DELETION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC;

EID: 27644570779     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087514     Document Type: Article

References (26)

1. Åkerblad P, Lind U, Liberg D, Bamberg K, Sigvardsson M: Early B-Cell Factor (O/E-1) is a promotor of adipogenesis and involved in control of genes important for terminal adipocyte differentiation. Mol Cell Biol 22:8015-8025 (2002).
2. Ashar HR, Schoenberg Fejzo M, Tkachenko A, Zhou X, Fletcher JA, Weremowicz S, Morton CC, Chada K: Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 82:57-65 (1995).
3. Ashar HR, Tkachenko A, Shan P, Chada K: HMGA2 is expressed in an allele-specific manner in human lipomas. Cancer Genet Cytogenet 143:160-168 (2003).
4. Borrmann L, Seebeck B, Rogalla P, Bullerdiek J: Human HMGA2 promoter is coregulated by a polymorphic dinucleotide (TC)-repeat. Oncogene 22:756-760 (2003).
5. Broberg K, Zhang M, Strömbeck B, Isaksson M, Nilsson M, Mertens F, Mandahl N, Panagopoulos I: Fusion of RDC1 with HMGA2 in lipomas as the result of chromosome aberrations involving 2q35→q37 and 12q13→q15. Int J Oncol 21:321-326 (2002).
6. Fedele M, Battista S, Manfioletti G, Croce CM, Giancotti V, Fusco A: Role of the high mobility group A proteins in human lipomas. Carcinogenesis 22:1583-1591 (2001).
7. Fletcher CDM, Unni KK, Mertens F: Adipocytic tumours, in Fletcher CDM, Unni KK, Mertens F (eds): World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone, pp 19-46 (IARC Press, Lyon 2002).
8. Gisselsson D: Refined characterization of chromosome aberrations in tumors by multicolor banding and electronic mapping resources. Methods Cell Sci 23:23-28 (2001).
9. Gisselsson D, Höglund M, Mertens F, Dal Cin P, Mandahl M: Hibernomas are characterized by homozygous deletions in the multiple endocrine neoplasia type I region. Am J Pathol 155:61-66 (1999).
10. ISCN (1995): An International System for Human Cytogenetic Nomenclature, Mitelman F (ed) (Karger, Basel 1995).
11. Lemke I, Rogalla P, Bullerdiek J: Large deletion of part of the HMGIC locus accompanying a t(3:12) (q27-q28;q14-q15) in a lipoma. Cancer Genet Cytogenet 129:161-164 (2001).
12. Liberg D, Sigvardsson M, Åkerblad P: The EBF/Olf/Collier family of transcription factors: regulators of differentiation in cells originating from all three embryonal germ layers. Mol Cell Biol 22:8389-8397 (2002).
13. Maire G, Forus A, Foa C, Bjerkehagen B, Mainguene C, Kresse SH, Myklebost O, Pedeutour F: 11q13 alterations in two cases of hibernoma: large heterozygous deletions and rearrangement breakpoints near GARP in 11q13.5. Genes Chromosomes Cancer 37:389-395 (2003).
14. rd ed, pp 165-203 (Oxford University Press, New York 2001).
15. Mandahl N, Höglund M, Mertens F, Rydholm A, Willen H, Brosjö O, Mitelman F: Cytogenetic aberrations in 188 benign and borderline adipose tissue tumors. Genes Chromosomes Cancer 9:207-215 (1994).
16. Menon, Ingraham: Unpublished data, NCBI (http://www.ncbi.nlm.nih.gov) (2004).
17. Merscher S, Marondel I, Pedeutour F, Gaudray P, Kucherlapati R, Turc-Carel C: Identification of new translocation breakpoints at 12q13 in lipomas. Genomics 46:70-77 (1997).
18. Mitelman F: Database of Chromosome Aberrations in Cancer. Mitelman F, Johansson B, Mertens F (eds). (http://cgap.nci.nih.gov/Chromosomes/Mitelman).
19. Nielsen GP, Mandahl N: Lipoma, in Fletcher CDM, Unni KK, Mertens F (eds): WHO Classification of Tumours. Pathology and Genetics of Tumors of Soft Tissue and Bone, pp 20-22 (IARC Press, Lyon 2002).
20. Panagopoulos I, Mertens F, Isaksson M, Mandahl N: A novel FUS/CHOP chimera in myxoid liposarcoma. Biochem Biophys Res Commun 279:838-845 (2000).
21. Panagopoulos I, Mertens F, Domanski HA, Isaksson M, Brosjo O, Gustafson P, Mandahl N: No EWS/FLI1 fusion transcripts in giant-cell tumors of bone. Int J Cancer 93:769-772 (2001).
22. Petit MMR, Mols R, Schoenmakers EFPM, Mandahl N, Van de Ven WJM: LPP, the preferred fusion partner gene of HMGIC in lipomas, is a novel member of the LIM protein gene family. Genomics 36:118-129 (1996).
23. Petit MMR, Schoenmakers EFPM, Huysman C, Geurts JMW, Mandahl N, Van de Ven WJM: LHFP, a novel translocation partner gene of HMGIC in a lipoma, is a member of a new family of LHFP-like genes. Genomics 57:438-441 (1999).
24. Schoenmakers EFPM, Wanschura S, Mols R, Bullerdiek J, Van den Berghe H, Van de Ven WJM: Recurrent rearrangements in the high mobility group protein gene, HMGIC, in benign mesenchymal tumours. Nat Genet 10:436-444 (1995).
25. Sgarra R, Rustighi A, Tessari MA, Di Bernardo J, Altamura S, Fusco A, Manfioletti G, Giancotti V: Nuclear phosphoproteins HMGA and their relationship with chromatin structure and cancer. FEBS Letters 574:1-8 (2004).
26. Sreekantaiah C, Leong SPL, Karakousis CP, McGee DL, Rappaport WD, Villar HV, Neal D, Fleming S, Wankel A, Herrington PN, Carmona R, Sandberg AA: Cytogenetic profile of 109 lipomas. Cancer Res 51:422-433 (1991).